Previous close | 0.0200 |
Open | 0.0400 |
Bid | 0.0000 |
Ask | 0.0900 |
Strike | 48.00 |
Expiry date | 2024-06-07 |
Day's range | 0.0100 - 0.0500 |
Contract range | N/A |
Volume | |
Open interest | 461 |
Bristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy Breyanzi (liso-cel) and three updated analyses on studies evaluating Opdivo at ASCO.
PRINCETON, N.J., June 04, 2024--Bristol Myers Squibb Announces Opdivo (nivolumab) Plus Yervoy (ipilimumab) Significantly Improved Overall Survival Compared to Lenvatinib or....
The simplest way to benefit from a rising market is to buy an index fund. But if you buy individual stocks, you can do...